UNE COMBINATION COMPRENANT UN VECTEUR ADÉNOVIRAL AVEC UN GÈNE DE LA THYMIDINE KINASE, GANCICLOVIR ET TEMOZOLOMIDE POUR LE TRAITEMENT DU GLIOBLASTOME MULTIFORME

• 收藏
• 分享

专利权人:

Gliotherapy Limited

发明人:

申请号：

EP12704527.6

公开号：

EP2665489B1

申请日:

2012.01.18

申请国别(地区):

EP

年份:

2017

代理人:

摘要：

An agent comprises a vector having a functional gene, a prodrug which can be converted into a cytotoxic agent by an expression product of the gene, and another cytotoxic agent, as a combined preparation for simultaneous, sequential or separate use in the therapy of cancer or of a disease characterised by an impaired mismatch repair (MMR) pathway, wherein the dosage regimen comprises beginning the another cytotoxic agent therapy no later than 7 days after the prodrug therapy has finished.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/